Biotech startup KeyNature has closed a $2.4m financing round. The round is fully financed by Eyrir Sprotar.
The company produces astaxanthin, an antioxidant dietary supplement. According to the company’s website the company is a vertically integrated biotech company that focuses on consumer health products from microalgae.
This was announced on the website of Einar Gunnar Guðmundsson, Chairman of SER Holdings – the investing arm of Arion Bank that invests in the startup companies that participate in the Startup Energy Reykjavik accelerator.
Norðurskautið reached out to both Eyrir Sprotar and Key Natura for further info and comments without replies.